Opportunity Information: Apply for CDC RFA GH17 177602CONT18
The grant opportunity titled "Strengthening Clinical Services of PLHIV in Central America under PEPFAR" is a continuation funding notice issued by the Centers for Disease Control and Prevention (CDC), specifically through its Center for Global Health (CGH). It is structured as a cooperative agreement, which usually means the CDC expects to have substantial involvement in the funded work, such as technical collaboration, ongoing guidance, and shared responsibility for achieving program goals. The overall activity category is health, and it falls under CFDA number 93.067, which is associated with global health and public health program support.
This particular announcement is not an open competition. It is explicitly described as continuation funding that is intended only for organizations that were previously awarded under the earlier funding opportunity CDC-RFA-GH17-1776, which carried the same program title. In practical terms, that means new applicants should not expect to be eligible unless they already hold the original award. The eligible applicant field is listed as "Others," but the description clarifies that eligibility is effectively restricted to existing grantees from the prior award cycle.
The program focus is on strengthening clinical services for people living with HIV (PLHIV) in Central America under PEPFAR (the US President's Emergency Plan for AIDS Relief). While the notice itself is brief and does not spell out specific required activities, the title and PEPFAR context point to work that typically supports improved quality and continuity of HIV care in clinical settings. This can include strengthening HIV treatment and monitoring systems, improving retention in care, enhancing adherence support, building capacity for clinical staff, improving service delivery models, and strengthening linkages across the HIV care continuum. In PEPFAR-supported clinical programs, the end goals commonly align with sustaining viral suppression, reducing HIV-related illness and mortality, and improving overall performance of HIV treatment programs.
Administratively, the opportunity number is listed as CDC RFA GH17 177602CONT18, indicating it is a continuation (CONT) action tied to the original GH17-1776 award. The original closing date shown is November 30, 2017, and the creation date is August 30, 2017, which reflects the timing of the original posting and aligns with the continuation nature of the award rather than signaling a new application window for the general public. The award ceiling is shown as 0, which often appears in continuation notices when the specific funding level is not stated in the public synopsis or is handled through internal continuation processes rather than a new competitive ceiling-based solicitation. The number of expected awards is not provided in the source data, which is also common for continuation-only announcements where the recipients are already determined by the prior competition.
In short, this CDC cooperative agreement supports ongoing PEPFAR-funded efforts to strengthen HIV clinical services for PLHIV in Central America, but it is designed solely to continue funding for previously selected grantees from the earlier CDC-RFA-GH17-1776 award rather than to solicit new proposals.Apply for CDC RFA GH17 177602CONT18
- The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthening Clinical Services of PLHIV in Central America under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on 2017-08-30.
- Applicants must submit their applications by 2017-11-30. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Strengthening Clinical Services of PLHIV in Central America under PEPFAR."
Which agency is offering this funding?
This is a Centers for Disease Control and Prevention (CDC) funding notice, issued through the CDC's Center for Global Health (CGH).
What type of funding mechanism is this?
It is a cooperative agreement. This typically means CDC expects substantial involvement in the funded work, such as technical collaboration, ongoing guidance, and shared responsibility for achieving program goals.
What is the overall activity category for this opportunity?
The overall activity category is health.
What CFDA number is associated with this announcement?
The CFDA number listed is 93.067, which is associated with global health and public health program support.
Is this an open, competitive funding opportunity?
No. This announcement is explicitly described as continuation funding and is not an open competition.
Who is eligible to apply for this continuation funding?
Eligibility is effectively restricted to organizations that were previously awarded under the earlier funding opportunity CDC-RFA-GH17-1776 (the prior award cycle with the same program title). New applicants should not expect to be eligible unless they already hold the original award.
The listing says "Eligible Applicants: Others." Does that mean anyone can apply?
No. While the eligible applicant field is shown as "Others," the description clarifies that the continuation funding is intended only for existing grantees from the earlier CDC-RFA-GH17-1776 award.
What is the program focus of this continuation award?
The focus is on strengthening clinical services for people living with HIV (PLHIV) in Central America under PEPFAR (the U.S. President's Emergency Plan for AIDS Relief).
Does the notice list specific required activities?
The notice is brief and does not spell out specific required activities. However, the title and PEPFAR context indicate work that typically supports improved quality and continuity of HIV care in clinical settings.
What kinds of activities are commonly supported under PEPFAR-related clinical strengthening efforts?
Based on the description and typical PEPFAR-supported clinical programs, activities commonly include strengthening HIV treatment and monitoring systems, improving retention in care, enhancing adherence support, building capacity for clinical staff, improving service delivery models, and strengthening linkages across the HIV care continuum.
What outcomes does this type of program generally aim to achieve?
End goals commonly align with sustaining viral suppression, reducing HIV-related illness and mortality, and improving overall performance of HIV treatment programs.
What is the opportunity number for this announcement?
The opportunity number is CDC RFA GH17 177602CONT18.
What does "CONT" in the opportunity number indicate?
"CONT" indicates it is a continuation action tied to the original GH17-1776 award rather than a new, open solicitation.
What is the relationship between this notice and CDC-RFA-GH17-1776?
This notice is a continuation funding announcement intended only for organizations that were previously awarded under CDC-RFA-GH17-1776, which carried the same program title.
Why does the announcement show an older closing date (November 30, 2017)?
The original closing date shown is November 30, 2017, which reflects the timing of the original posting and aligns with the continuation nature of this notice rather than signaling a new application window for the general public.
Why does the announcement show a creation date of August 30, 2017?
The creation date (August 30, 2017) reflects when the original opportunity was posted and is consistent with this being tied to the earlier award cycle.
What is the award ceiling for this opportunity?
The award ceiling is shown as 0. In continuation notices, this often appears when the specific funding level is not stated in the public synopsis or is handled through internal continuation processes rather than a new competitive ceiling-based solicitation.
Is the number of expected awards stated?
No. The number of expected awards is not provided in the source information, which is common for continuation-only announcements where the recipients are already determined by the prior competition.
Is this funding meant to start a new project, or to continue an existing one?
This is continuation funding intended to support ongoing efforts under an existing award, not to solicit new proposals from new applicants.
What region does the program cover?
The program focus is Central America.
Who are the intended beneficiaries of the strengthened clinical services?
The intended beneficiaries are people living with HIV (PLHIV).
How involved is CDC expected to be during the project?
Because this is a cooperative agreement, CDC is expected to have substantial involvement, such as technical collaboration and ongoing guidance, with shared responsibility for achieving program goals.
Browse more opportunities from the same category: Health
Next opportunity: National Research Mentoring Network (NRMN) Resource Center (U24 - Clinical Trial Not Allowed)
Previous opportunity: Biomedical Technology Research Resource (P41)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH17 177602CONT18
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH17 177602CONT18) also looked into and applied for these:
| Funding Opportunity |
|---|
| Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under PEPFAR Apply for CDC RFA GH15 151004CONT18 Funding Number: CDC RFA GH15 151004CONT18 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Establishment of a Strategic Partnership to Strengthen the COMISCA under PEPFAR Apply for CDC RFA GH15 150904CONT18 Funding Number: CDC RFA GH15 150904CONT18 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) Apply for PAR 17 466 Funding Number: PAR 17 466 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21) Apply for PAR 17 463 Funding Number: PAR 17 463 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21) Apply for PAR 17 474 Funding Number: PAR 17 474 Agency: National Institutes of Health Category: Health Funding Amount: $125,000 |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44) Apply for PAR 17 480 Funding Number: PAR 17 480 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44) Apply for PAR 17 479 Funding Number: PAR 17 479 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Repurposing Target-Based Pharmaceutical Libraries for Discovery of Therapeutics against Eukaryotic Pathogens (R21/R33) Apply for RFA AI 17 036 Funding Number: RFA AI 17 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33 Clinical Trial Optional) Apply for RFA AI 17 028 Funding Number: RFA AI 17 028 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA)Individual Postdoctoral Fellowship (F32) Apply for PA 17 481 Funding Number: PA 17 481 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Comparative Genomics Research Program (R01) Apply for PAR 17 482 Funding Number: PAR 17 482 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improved Quality and Sustainability of Medication Assisted Treatment in Ukraine under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 159403CONT18 Funding Number: CDC RFA GH15 159403CONT18 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| NIMH Research Education Mentoring Programs for HIV/AIDS Researchers (R25) Apply for PAR 17 485 Funding Number: PAR 17 485 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Accessible Continuum of Care and Essential Services Sustained (ACCESS) Apply for RFI 687 17 002 Funding Number: RFI 687 17 002 Agency: Madagascar USAID-Antananarivo Category: Health Funding Amount: $85,000,000 |
| Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R34) Apply for RFA RM 17 024 Funding Number: RFA RM 17 024 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (U01) Apply for RFA RM 17 023 Funding Number: RFA RM 17 023 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIH Science Education Partnership Award (SEPA) (R25) Apply for PAR 17 339 Funding Number: PAR 17 339 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54) Apply for RFA RM 17 020 Funding Number: RFA RM 17 020 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Science of Behavior Change: Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R21) Apply for RFA RM 17 028 Funding Number: RFA RM 17 028 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R01) Apply for RFA RM 17 022 Funding Number: RFA RM 17 022 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH17 177602CONT18", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.